Oncology has dominated the BioPharma pipeline for over a decade and shows no sign of relinquishing that position. The volume of oncology assets in development across European and global pharmaceutical and biotech companies creates persistent, significant demand for senior oncology leadership — from Chief Medical Officers with oncology depth to Heads of Clinical Development, VP Medical Affairs and senior scientific leads across solid tumours, haematology and immuno-oncology.
The competitive reality of the European oncology talent market
The European oncology talent market at senior level is both active and intensely competitive. The same candidates tend to be known to multiple companies simultaneously. A VP of Oncology Clinical Development with strong solid tumour credentials and European regulatory experience is on the radar of several organisations at any given moment — and the companies that succeed in attracting them are rarely those that move the slowest or offer the least compelling vision.
Switzerland and the UK remain the dominant geographies for oncology leadership hiring in Europe, driven by the concentration of major pharmaceutical headquarters and a well-developed biotech ecosystem. Denmark has grown significantly as an oncology hiring hub, driven by the expansion of major Nordic pharma players. Germany is increasingly active particularly in haematology and precision oncology.
In oncology executive search, the best candidates aren't found — they're already known. The search firms that consistently place well in this space are the ones that have spent years building relationships within the oncology scientific and medical community.
What organisations are looking for in senior oncology leaders
Therapeutic area depth remains the non-negotiable baseline — solid tumours, haematology, immuno-oncology, precision oncology each have their own scientific and clinical communities and a track record in one doesn't automatically transfer to another. Beyond that, the most valued oncology leaders combine scientific credibility with the ability to lead large, international teams and to represent the organisation's oncology strategy externally to regulators, investigators, payers and investors.
The interface between oncology clinical development and medical affairs has become increasingly important. Senior oncology leaders who understand how clinical evidence generation connects to reimbursement strategy and real-world evidence — and who can build relationships across those functions — are particularly sought after across both large pharma and biotech.
What the search process looks like in oncology
Senior oncology searches require search partners with genuine depth in the oncology community. The talent pool is relatively concentrated and well-networked — candidates know each other, they know who is working on what and they tend to be sceptical of approaches from firms that don't demonstrate genuine sector knowledge. Reference checks in oncology run deep and reputations — of companies, of leaders and of search partners — travel fast within the community.